Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Drowsiness | postmarketing, 32% | x | x | |
Ataxia | postmarketing, 13% | x | x | |
Dizziness | postmarketing, 7.6% | x | x | |
Speech disorder | postmarketing, 2% | x | ||
Digestion impaired | 1% | x | x | |
Confusional state | postmarketing, 1% | x | x | |
Headache | postmarketing, 1% | x | x | |
Nausea | postmarketing, 1% | x | x | |
Vomiting | postmarketing, 1% | x | x | |
Sleep disorder | postmarketing, 1% | x | ||
Aggression | postmarketing | x | x | |
Anger | postmarketing | x | x | |
Anorexia | postmarketing | x | ||
Mental disorder | postmarketing | x | ||
Connective tissue disorder | postmarketing | x | ||
Delusion | postmarketing | x | x | |
Diplopia | postmarketing | x | x | |
Emotional disturbance NOS | postmarketing | x | ||
Rash | postmarketing | x | x | |
Eye disorder | postmarketing | x | ||
Fatigue | postmarketing | x | x | |
Fracture | postmarketing | x | x | |
Gastrointestinal disorder | postmarketing | x | ||
Hallucination | postmarketing | x | x | |
Cardiac arrest | postmarketing | x | x | |
Cardiac disorder | postmarketing | x | ||
Cardiac failure | postmarketing | x | x | |
Hypotension | postmarketing | x | x | |
Incontinence | postmarketing | x | x | |
Irritability | postmarketing | x | x | |
Nervous system disorder | postmarketing | x | ||
Nervousness | postmarketing | x | ||
Nightmare | postmarketing | x | x | |
Palpitations | postmarketing | x | x | |
Pruritus | postmarketing | x | x | |
Psychotic disorder | postmarketing | x | x | |
Convulsion | postmarketing | x | x | |
Muscle spasms | postmarketing | x | x | |
Tachycardia | postmarketing | x | x | |
Tremor | postmarketing | x | ||
Dry mouth | postmarketing | x | x | |
Agitation | postmarketing | x | ||
Muscular weakness | postmarketing | x | x | |
Haemoglobin decreased | postmarketing | x | x | |
Malnutrition | postmarketing | x | x | |
Unspecified disorder of skin and subcutaneous tissue | postmarketing | x | x | |
Anterograde amnesia | postmarketing | x | x | |
Respiratory depression | postmarketing | x | x | |
Vision blurred | postmarketing | x | x | |
Alertness decreased | postmarketing | x | x | |
Anaphylactic shock | x | |||
Hostility | x | |||
Hypersensitivity | x | |||
Emotional disorder | x | |||
Euphoric mood | x | |||
Excitability | x | |||
Blood glucose decreased | x | |||
White blood cell count decreased | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Agitation | x | |||
Anxiety | x | x | ||
Anxiety disorder | x | |||
Anxiety neurosis | x | |||
Distress | x | |||
Tension | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |